The estimated Net Worth of Christopher Fikry is at least $664 ezer dollars as of 26 November 2019. Mr. Fikry owns over 7,400 units of PPD Inc stock worth over $664,048 and over the last 5 years he sold PPD stock worth over $0. In addition, he makes $0 as Executive Vice President - Global Laboratory Services at PPD Inc.
Christopher has made over 1 trades of the PPD Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 7,400 units of PPD stock worth $199,800 on 26 November 2019.
The largest trade he's ever made was buying 7,400 units of PPD Inc stock on 26 November 2019 worth over $199,800. On average, Christopher trades about 1,480 units every 0 days since 2019. As of 26 November 2019 he still owns at least 14,045 units of PPD Inc stock.
You can see the complete history of Mr. Fikry stock trades at the bottom of the page.
Christopher Fikry serves as Executive Vice President - Global Laboratory Services of the Company. Prior to joining the Company, Mr. Fikry served in various roles at Quest Diagnostics (DGX), from September 2012 to May 2017, including as vice president and general manager of oncology and companion diagnostics, and at Novartis AG (NUS) Vaccines and Diagnostics, from January 2007 to September 2012, including as director of strategic planning, head of the U.S. meningococcal and the U.S. influenza and travel vaccine franchises and vice president of U.S. marketing. He began his career in the healthcare practice of The Boston Consulting Group Inc.
Christopher Fikry is 43, he's been the Executive Vice President - Global Laboratory Services of PPD Inc since 2017. There are 14 older and 4 younger executives at PPD Inc. The oldest executive at PPD Inc is Jeffrey Kindler, 64, who is the Independent Director.
Christopher's mailing address filed with the SEC is C/O PPD, INC., 929 NORTH FRONT STREET, WILMINGTON, NC, 28401.
Over the last 22 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt... és Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
PPD Inc executives and other stock owners filed with the SEC include: